Shunsuke Yamamoto

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.

Gentaro Kawano, Riichiro Ikeda, Daisuke Ishihara

|Jan 06, 2025
Access Program for Unapproved and Off-Label Drug Use in Pediatric BRAF V600E-Mutated Brain Tumors in Japan.

Maya Suzuki, Yuhki Koga, Terumi Kawasaki

|Sep 18, 2024
Early defibrotide therapy and risk factors for post-transplant veno-occlusive disease/sinusoidal obstruction syndrome in childhood.

Hironori Goto, Utako Oba, Tamaki Ueda

|Jan 01, 2024
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism.

Kiwamu Hatakeyama, Yoshikane Kikushige, Daisuke Ishihara

|Oct 03, 2023
Pediatric leukemia and maternal occupational exposure to anticancer drugs: the Japan Environment and Children's Study.

Shunsuke Yamamoto, Masafumi Sanefuji, Maya Suzuki

Pageof 2

Frequent Collaborators

2 joint publications

Wakako Kato

2 joint publications

Tamaki Ueda

2 joint publications

Daisuke Ishihara

2 joint publications

Hironori Goto